The landscape of modern pharmaceutical research has been fundamentally altered by the advent of protein structure prediction tools, most notably…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The pharmaceutical industry has long been defined by the pursuit of the "druggable" genome—a subset of proteins whose stable, pocketed…
Read MoreA plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmacology is currently undergoing a paradigm shift, one defined by a departure from the rigid structural…
Read More
Skipping the words could make some AI reasoning more efficient
The current paradigm of artificial intelligence development, dominated by Large Language Models (LLMs), relies heavily on a technique known as…
Read More
A plate of spaghetti: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding
The landscape of modern pharmacology has been fundamentally reshaped by the advent of artificial intelligence, most notably by the breakthrough…
Read MoreSkipping the words could make some AI reasoning more efficient
The current paradigm of artificial intelligence development relies heavily on a methodology known as chain-of-thought (CoT) prompting. By compelling Large…
Read More
Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
Terray Therapeutics, a burgeoning startup based in the Los Angeles area, has unveiled TerraBind, a groundbreaking potency prediction model designed…
Read More
Terray says TerraBind delivers 26x faster inference than Boltz-2 by skipping diffusion-based coordinate generation
In a significant development for AI-driven drug discovery, Terray Therapeutics, a Los Angeles-area startup, has introduced TerraBind, a novel potency…
Read More
